B cell-associated immune profiles in patients with end-stage renal disease (ESRD)

Experimental and Molecular Medicine

Volumn 44, Issue 8, 2012, Pages 465-472

  Kim, Kyoung Woon ^a,b   Chung, Byung Ha ^a   Jeon, Eun Joo ^a,b   Kim, Bo Mi ^a,b   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Kim, Yong Soo ^a   Cho, Seok Goo ^a,c   Cho, Mi La ^a,b   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

B iymphoid; B lymphocyte subsets; Chronic; Kidney failure; Precursor cells; Renal dialysis

Indexed keywords

CD19 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 4;

ADULT; ARTICLE; B LYMPHOCYTE; CD19+ B LYMPHOCYTE; CELL MATURATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; INTERLEUKIN 10 BLOOD LEVEL; KIDNEY FAILURE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAINTENANCE THERAPY; MALE; MEMORY CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOLUNTEER;

EID: 84865399361     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2012.44.8.053     Document Type: Article

References (34)

1. Alvarez-Lara MA, Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Madueno JA, Aljama P. The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 2004;19:3084-90
2. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010;32:129-40
3. Chiu CW, Dalton M, Ishiai M, Kurosaki T, Chan AC. BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins. EMBO J 2002;21:6461-72
4. Chung BH, Kim KW, Sun IO, Choi SR, Park HS, Jeon EJ, Kim BM, Choi BS, Park CW, Kim YS, Cho ML, Yang CW. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett 2012; 141:181-9
5. de Graeff PA, Dankert J, de Zeeuw D, Gips CH, van der Hem GK. Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-up. Nephron 1985;40:155-60
6. Ettinger R, Kuchen S, Lipsky PE. The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev 2008;223:60-86
7. Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, de Francisco AL, Lopez-Hoyos M, Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 2000;15:502-10
8. Fu C, Turck CW, Kurosaki T, Chan AC. BLNK: a central linker protein in B cell activation. Immunity 1998;9:93-103
9. Girndt M, Kohler H, Schiedhelm-Weick E, Meyer zum Buschenfelde KH, Fleischer B. T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993;44:359-65
10. Girndt M, Sester U, Sester M, Kaul H, Khler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999;14:2807-10
11. Grabbe A, Wienands J. Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes. Blood 2006;108:3761-8
12. Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W, Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 1998;187:663-74
13. Haag-Weber M, Horl WH. Uremia and infection: mechanisms of impaired cellular host defense. Nephron 1993;63:125-31
14. Jeong IK, Oh da H, Park SJ, Kang JH, Kim S, Lee MS, Kim MJ, Hwang YC, Ahn KJ, Chung HY, Chae MK, Yoo HJ. Inhibition of NF-kappaB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med 2011;43:684-92
15. Jumaa H, Hendriks RW, Reth M. B cell signaling and tumorigenesis. Annu Rev Immunol 2005;23:415-45
16. Kang SM, Narducci MG, Lazzeri C, Mongiovi AM, Caprini E, Bresin A, Martelli F, Rothstein J, Croce CM, Cooper MD, Russo G. Impaired T- and B-cell development in Tcl1-deficient mice. Blood 2005;105:1288-94
17. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, Beaumont T, Tedder TF, van Noesel CJ, Eldering E, van Lier RA. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010;120:214-22
18. Kurosaki T, Tsukada S. BLNK: connecting Syk and Btk to calcium signals. Immunity 2000;12:1-5
19. Meuer SC, Hauer M, Kurz P, Meyer zum Buschenfelde KH, Kohler H. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987;80: 743-9
20. Minegishi Y, Rohrer J, Coustan-Smith E, Lederman HM, Pappu R, Campana D, Chan AC, Conley ME. An essential role for BLNK in human B cell development. Science 1999;286:1954-7
21. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010;120: 1836-47
22. Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, Morse HC 3rd, Liu C, Schwartzberg PL, Leonard WJ. A critical role for IL-21 in regulating immunoglobulin production. Science 2002;298:1630-4
23. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF, Hwu P, Shaffer DJ, Akilesh S, Roopenian DC, Morse HC 3rd, Lipsky PE, Leonard WJ. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004;173:5361-71
24. Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant 2010;25:205-12
25. Pappu R, Cheng AM, Li B, Gong Q, Chiu C, Griffin N, White M, Sleckman BP, Chan AC. Requirement for B cell linker protein (BLNK) in B cell development. Science 1999;286: 1949-54
26. Plebani A, Lougaris V, Soresina A, Meini A, Zunino F, Losi CG, Gatta R, Cattaneo G, Nespoli L, Marinoni M, Capolunghi F, Vivarelli M, Quinti I, Carsetti R. A novel immunodeficiency characterized by the exclusive presence of transitional B cells unresponsive to CpG. Immunology 2007;121:183-8
27. Raskova J, Ghobrial I, Czerwinski DK, Shea SM, Eisinger RP, Raska K Jr. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987;147:89-93
28. Simeoni L, Kliche S, Lindquist J, Schraven B. Adaptors and linkers in T and B cells. Curr Opin Immunol 2004;16:304-13
29. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8
30. Tan JE, Wong SC, Gan SK, Xu S, Lam KP. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes. J Biol Chem 2001;276:20055-63
31. Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML, Liou HC. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur J Immunol 1998;28:4299-312
32. Vanholder R, Ringoir S, Dhondt A, Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991;39:320-7
33. Woo YJ, Yoon BY, Jhun JY, Oh HJ, Min SW, Cho ML, Park SH, Kim HY, Min JK. Regulation of B cell activating factor (BAFF) receptor expression by NF-KappaB signaling in rheumatoid arthritis B cells. Exp Mol Med 2011;43:350-7
34. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 2006;70:371-6